This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the federal Research Related to Deafness and Communication Disorders program (CFDA 93.173), provides $304,723 to Qualia Oto, Inc. to assess the viability of robotic-assisted, shape-conforming cochlear implant (CI) electrode arrays. The goal is to develop a new CI technology that can achieve atraumatic cochlear implantation and optimal electrode positioning simultaneously,...
Qualia Oto, Inc. was awarded a $233,928 Project Grant from the National Science Foundation to develop matrix-addressed, thin-film cochlear implant electrode arrays. The NSF funding supports a Small Business Technology Transfer Phase I project under the Technology, Innovation, and Partnerships program. The award will enable Qualia Oto to establish the feasibility of a novel circuit design fabricated on a thin-film platform using standard manufacturing equipment. Prototypes will undergo electrical...
The National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), awarded a $306,073 Project Grant to Iotamotion, Inc. to develop a navigation-based cochlear implant insertion system that optimizes trajectory while enabling slow and consistent electrode array insertions. The goal is to improve short and long-term hearing outcomes for cochlear implant patients by enhancing structural preservation...
This federal Project Grant award for $682,911.00 was provided by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173). The grant aims to study the perceptual adaptation process that occurs in cochlear implant (CI) users after initial device activation, with the goal of improving speech perception and sound quality outcomes. The key research objectives include: Longitudinally...
This Project Grant award of $187,510 from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), aims to investigate the mechanisms and clinical impact of neo-ossification (new bone formation) following cochlear implantation. The key objectives are to: 1) leverage advanced imaging techniques to assess in-vivo cochlear neo-ossification in human and mouse cochlear implant recipients, 2)...
The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded a $306,872 Project Grant under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) to Iotamotion, Inc. The goal of this 1-year award, with a period of performance from July 15, 2025 to June 30, 2026, is to develop a novel electromagnetic (EM) tracking system called EMOTO that can be integrated into Iotamotion's robotic-assist cochlear implant (CI) insertion system. The EMOTO system...
This federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), provides $674,021 to advance the development of an implantable middle-ear microphone system. The award aims to refine and test a prototype microphone, called the UMIC, that can be used in totally-implantable cochlear implants to take advantage of outer-ear acoustic benefits. Key objectives...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD) under CFDA 93.173 "Research Related to Deafness and Communication Disorders" provides $637,500.00 to the Massachusetts Eye and Ear Infirmary to conduct research on understanding human cochlear micromechanics. The goal is to study the forward transduction that drives inner and outer hair cell stereocilia, as well as the reverse transduction that amplifies organ of Corti motion...
This federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), provides $251,856 to New York University from September 1, 2024 to August 31, 2026. The funding supports research investigating the neuroplastic processes underlying early adaptation to cochlear implants, which restore hearing and speech perception in individuals with severe or profound...
This Project Grant award, valued at $377,700.00, was provided by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173). The goal of the research is to develop and validate a reliable clinical decision support tool for early risk stratification of cochlear implant (CI) speech perception performance. The project aims to integrate novel biomarkers, patient comorbidities, and social...